Skip to main content

Table 1 Population characteristics

From: Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Gender

   
 

Male

19

66 %

 

Female

10

33 %

Age at diagnosis

   
  

18,1

 
 

median (min-max)

19

8 – 65

Age at initiation of treatment

   
  

19

 
 

median (min-max)

20

9 – 72

 

≤18 years

15

45 %

Histological subtype of osteosarcoma

   
 

osteoblastic

18

62 %

 

chondroblastic

5

17 %

 

osteogenic

3

10 %

 

telangiectasic

2

7 %

 

pleiomorphic

1

4 %

Tumor grade

   
 

Grade III

29

100 %

Stage at beginning of TT

   
 

progression

30

91 %

 

complete remission after relapse

3

9 %

Localization of relapse

   
 

localized

0

0 %

 

metastatic

24

73 %

 

both

9

27 %

Number of previous treatment lines

   
  

2,9

 
 

median (min-max)

3

1 – 8

 

0

0

0 %

 

1

4

12 %

 

2

12

36 %

 

3

10

30 %

 

≥4

7

21 %

Delay diagnosis - initiation of TT

   
  

2,8 years

 
 

median (min-max)

2,7 years

(0,6 – 7 years)